Dr Reddys Laboratories (RDY) EBIT Margin (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded EBIT Margin of 14.63% in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 5.26 percentage points from 19.89% a year earlier but up 9.94 percentage points from the prior quarter.
Dr Reddys Laboratories (RDY) EBIT Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' EBIT Margin came in at 9.74% as of Sep 30, 2026, down 11.12 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at 16.00%, down 6.10 percentage points from FY2025.
- Annual EBIT Margin has a five-year change of +3.20 percentage points (FY2021 to FY2026).
- Across earlier fiscal years, EBIT Margin came in at 22.09% in FY2025 (-2.17 pp), 24.27% in FY2024 (+1.04 pp), 23.23% in FY2023 (+9.46 pp) and 13.77% in FY2022 (+0.97 pp).
- Quarterly EBIT Margin has ranged from 1.76% in fiscal Q4 2026 to 26.14% in fiscal Q4 2023 over the past five years.
- On a year-over-year basis, EBIT Margin has declined for 11 consecutive quarters, with an average year-over-year change of -6.61 percentage points over the last eight quarters.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 23.35 percentage points in fiscal Q4 2023, against a drop of 18.98 percentage points in fiscal Q4 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 4.69% (Q1 2027), 1.76% (Q4 2026) and 16.32% (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 32.98% |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 14.63% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 14.63% |
| Jun 30, 2026 | 4.69% |
| Mar 31, 2026 | 1.76% |
| Dec 31, 2025 | 16.32% |
| Sep 30, 2025 | 19.89% |
| Jun 30, 2025 | 20.45% |
| Mar 31, 2025 | 20.75% |
| Dec 31, 2024 | 22.40% |
| Sep 30, 2024 | 21.89% |
| Jun 30, 2024 | 23.36% |
| Mar 31, 2024 | 21.12% |
| Dec 31, 2023 | 23.93% |
| Sep 30, 2023 | 25.97% |
| Jun 30, 2023 | 25.97% |
| Mar 31, 2023 | 26.14% |
| Dec 31, 2022 | 19.69% |
| Sep 30, 2022 | 24.27% |
| Jun 30, 2022 | 25.59% |
| Mar 31, 2022 | 2.79% |
| Dec 31, 2021 | 10.46% |
Dr Reddys Laboratories EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();